Mark W Lingen Selected Research

Mark W Lingen Research Topics

Disease

40	Neoplasms (Cancer) 11/2023 - 07/2002
24	Squamous Cell Carcinoma of Head and Neck 01/2023 - 07/2002
10	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 02/2003
9	Mouth Neoplasms (Oral Cancer) 12/2022 - 01/2008
3	Neoplasm Metastasis (Metastasis) 12/2020 - 06/2012
3	Carcinoma (Carcinomatosis) 11/2018 - 12/2013
3	Carcinogenesis 02/2011 - 04/2009
2	Oropharyngeal Neoplasms 11/2023 - 07/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2021 - 01/2018
2	Inflammation (Inflammations) 01/2017 - 03/2016
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 06/2014 - 03/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2012 - 01/2012
2	Lung Neoplasms (Lung Cancer) 08/2011 - 01/2008
2	Wounds and Injuries (Trauma) 09/2006 - 01/2002
1	Tongue Neoplasms (Tongue Neoplasm) 11/2023
1	COVID-19 01/2021
1	Acute Lung Injury 01/2017
1	Lung Injury 01/2017
1	Exanthema (Rash) 02/2016
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Arteritis 12/2015
1	Thyroid Neoplasms (Thyroid Cancer) 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Verrucous Carcinoma 04/2014
1	Hyperplasia 04/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2003
9	Messenger RNA (mRNA)IBA 12/2020 - 05/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
7	Proteins (Proteins, Gene)FDA Link 03/2016 - 05/2004
7	ErbB Receptors (EGF Receptor)IBA 02/2016 - 11/2005
5	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 04/2009
5	Phosphotransferases (Kinase)IBA 04/2015 - 11/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2010 - 01/2002
3	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 05/2006
3	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2022 - 05/2006
3	CytokinesIBA 01/2017 - 04/2008
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2015 - 01/2013
3	RNA (Ribonucleic Acid)IBA 01/2015 - 07/2012
2	Interferon Type IIBA 01/2023 - 12/2015
2	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 01/2016
2	CarcinogensIBA 01/2022 - 05/2013
2	CrizotinibIBA 01/2018 - 04/2009
2	Proto-Oncogene Proteins c-metIBA 01/2018 - 04/2009
2	AntibodiesIBA 01/2017 - 01/2002
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 02/2011
2	Cetuximab (Erbitux)FDA Link 01/2016 - 06/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2014 - 04/2009
2	tyrosine receptor (receptor, tyrosine)IBA 12/2014 - 01/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013 - 07/2012
2	ParaffinIBA 01/2013 - 07/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2011 - 11/2010
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2011 - 11/2010
2	Gefitinib (Iressa)FDA Link 07/2010 - 11/2005
2	MicroRNAs (MicroRNA)IBA 04/2010 - 01/2009
2	Mitogen-Activated Protein KinasesIBA 01/2009 - 06/2006
1	ORALIT (ORS)IBA 11/2023
1	InterferonsIBA 01/2023
1	pembrolizumabIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 11/2022
1	ChitosanIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 03/2018
1	Hormones (Hormone)IBA 03/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2018
1	Ligases (Synthetase)IBA 03/2017
1	LipopolysaccharidesIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2016
1	Calcium-Binding ProteinsIBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	Immunoglobulins (Immunoglobulin)IBA 12/2015
1	Matrix Metalloproteinases (MMPs)IBA 09/2015
1	IodineIBA 04/2015
1	Axitinib (AG 013736)IBA 04/2015
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2015
1	epidermal growth factor receptor VIIIIBA 01/2015
1	EphB4 ReceptorIBA 12/2014
1	PeriostinIBA 06/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	Autophagy-Related ProteinsIBA 01/2014
1	PlatinumIBA 01/2014
1	MAP-kinase-activated kinase 2IBA 01/2014

Therapy/Procedure

12	Therapeutics 03/2018 - 07/2002
4	Drug Therapy (Chemotherapy) 11/2022 - 05/2004
4	Radiotherapy 11/2022 - 05/2006
3	Immunotherapy 01/2023 - 01/2019
3	Oral Pathology 06/2021 - 03/2008
3	Oral Diagnosis (Oral Examination) 01/2021 - 01/2008
3	Induction Chemotherapy 01/2016 - 05/2006
2	Chemoprevention 01/2018 - 02/2011
2	Chemoradiotherapy 01/2014 - 07/2010
2	Dental Care 05/2012 - 05/2010
1	Re-Irradiation 11/2022
1	Immunomodulation 12/2015
1	Prostatectomy (Retropubic Prostatectomy) 01/2015
1	Warm Ischemia 01/2014